The perimenopause, depressive disorders, and hormonal variability

CONTEXT: Several investigations have postulated that the perimenopause may represent a period of increased psychiatric vulnerability, particularly for mood disorders. This review characterizes the perimenopause, including biological changes, the influence of psychosocial factors and the most common clinical manifestations. Clinic-based studies and community-based surveys addressing the prevalence of depressive symptoms in perimenopausal women are critically reviewed. We also discuss the potential greater vulnerability to mood disturbance during the perimenopause in response to hormonal variability. A therapeutic algorithm for management of depressive symptoms in middle-aged perimenopausal women is also presented. The role of estrogen in the treatment of perimenopausal depressive symptoms is particularly discussed. In addition, we review the existing data regarding the potential efficacy of estrogen as an antidepressant agent (monotherapy, augmentation strategy or prophylaxis). DESIGN: Narrative review.

Saved in:
Bibliographic Details
Main Authors: Soares,Cláudio de Novaes, Cohen,Lee Stuart
Format: Digital revista
Language:English
Published: Associação Paulista de Medicina - APM 2001
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802001000200008
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-31802001000200008
record_format ojs
spelling oai:scielo:S1516-318020010002000082001-03-19The perimenopause, depressive disorders, and hormonal variabilitySoares,Cláudio de NovaesCohen,Lee Stuart Perimenopause Depression Review Estrogen Treatment CONTEXT: Several investigations have postulated that the perimenopause may represent a period of increased psychiatric vulnerability, particularly for mood disorders. This review characterizes the perimenopause, including biological changes, the influence of psychosocial factors and the most common clinical manifestations. Clinic-based studies and community-based surveys addressing the prevalence of depressive symptoms in perimenopausal women are critically reviewed. We also discuss the potential greater vulnerability to mood disturbance during the perimenopause in response to hormonal variability. A therapeutic algorithm for management of depressive symptoms in middle-aged perimenopausal women is also presented. The role of estrogen in the treatment of perimenopausal depressive symptoms is particularly discussed. In addition, we review the existing data regarding the potential efficacy of estrogen as an antidepressant agent (monotherapy, augmentation strategy or prophylaxis). DESIGN: Narrative review.info:eu-repo/semantics/openAccessAssociação Paulista de Medicina - APMSao Paulo Medical Journal v.119 n.2 20012001-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802001000200008en10.1590/S1516-31802001000200008
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Soares,Cláudio de Novaes
Cohen,Lee Stuart
spellingShingle Soares,Cláudio de Novaes
Cohen,Lee Stuart
The perimenopause, depressive disorders, and hormonal variability
author_facet Soares,Cláudio de Novaes
Cohen,Lee Stuart
author_sort Soares,Cláudio de Novaes
title The perimenopause, depressive disorders, and hormonal variability
title_short The perimenopause, depressive disorders, and hormonal variability
title_full The perimenopause, depressive disorders, and hormonal variability
title_fullStr The perimenopause, depressive disorders, and hormonal variability
title_full_unstemmed The perimenopause, depressive disorders, and hormonal variability
title_sort perimenopause, depressive disorders, and hormonal variability
description CONTEXT: Several investigations have postulated that the perimenopause may represent a period of increased psychiatric vulnerability, particularly for mood disorders. This review characterizes the perimenopause, including biological changes, the influence of psychosocial factors and the most common clinical manifestations. Clinic-based studies and community-based surveys addressing the prevalence of depressive symptoms in perimenopausal women are critically reviewed. We also discuss the potential greater vulnerability to mood disturbance during the perimenopause in response to hormonal variability. A therapeutic algorithm for management of depressive symptoms in middle-aged perimenopausal women is also presented. The role of estrogen in the treatment of perimenopausal depressive symptoms is particularly discussed. In addition, we review the existing data regarding the potential efficacy of estrogen as an antidepressant agent (monotherapy, augmentation strategy or prophylaxis). DESIGN: Narrative review.
publisher Associação Paulista de Medicina - APM
publishDate 2001
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802001000200008
work_keys_str_mv AT soaresclaudiodenovaes theperimenopausedepressivedisordersandhormonalvariability
AT cohenleestuart theperimenopausedepressivedisordersandhormonalvariability
AT soaresclaudiodenovaes perimenopausedepressivedisordersandhormonalvariability
AT cohenleestuart perimenopausedepressivedisordersandhormonalvariability
_version_ 1756421459128877056